<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="16856">Glutathione</z:chebi>-S-transferase of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">Pi</z:e> class (GSTP1) is frequently overexpressed in a variety of <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> and has been identified as a potential therapeutic target for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> therapy </plain></SENT>
<SENT sid="1" pm="."><plain>GSTP1 is a phase II detoxification enzyme and conjugates the <z:chebi fb="0" ids="47923">tripeptide</z:chebi> <z:chebi fb="0" ids="16856">glutathione</z:chebi> to endogenous metabolites and <z:chebi fb="0" ids="35703">xenobiotics</z:chebi>, thereby limiting the efficacy of antitumor chemotherapeutic treatments </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, GSTP1 regulates cellular stress responses and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> by sequestering and inactivating c-Jun N-terminal kinase (JNK) </plain></SENT>
<SENT sid="3" pm="."><plain>Thiazolides are a novel class of antibiotics for the treatment of intestinal pathogens with no apparent side effects on the host cells and tissue </plain></SENT>
<SENT sid="4" pm="."><plain>Here we show that thiazolides induce a GSTP1-dependent and <z:chebi fb="0" ids="16856">glutathione</z:chebi>-enhanced cell <z:hpo ids='HP_0011420'>death</z:hpo> in <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> cell lines </plain></SENT>
<SENT sid="5" pm="."><plain>Downregulation of GSTP1 reduced the apoptotic activity of thiazolides, whereas overexpression enhanced it </plain></SENT>
<SENT sid="6" pm="."><plain>Thiazolide treatment caused strong Jun kinase activation and Jun kinase-dependent <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>As a critical downstream target of Jun kinase we identified the pro-apoptotic Bcl-2 homolog <z:chebi fb="3" ids="33173">Bim</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>Thiazolides induced <z:chebi fb="3" ids="33173">Bim</z:chebi> expression and activation in a JNK-dependent manner </plain></SENT>
<SENT sid="9" pm="."><plain>Downregulation of <z:chebi fb="3" ids="33173">Bim</z:chebi> in turn significantly blocked thiazolide-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="10" pm="."><plain>Whereas low concentrations of thiazolides failed to induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> directly, they potently sensitized <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells to TNF-related <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-inducing ligand- and chemotherapeutic drug-induced cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Although GSTP1 overexpression generally limits chemotherapy and thus antitumor treatment, our study identifies GSTP1 as Achilles' heel and thiazolides as novel interesting <z:mpath ids='MPATH_3'>apoptosis</z:mpath> sensitizer for the treatment of <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> </plain></SENT>
</text></document>